Lower riskDrug recall · FDA · Published February 3, 2022
STAQ Pharma recalls Hydro morphine syringes with incorrect labeling
STAQ Pharma recalls 50mL single-dose hydro morphine syringes with incorrect morphine sulfate labeling. This could lead to medication errors if used without proper identification.
Labeling: Label Mix up; A limited number of syringes containing HYDROmorphone HCl PF were incorrectly labeled as Morphine Sulfate PF with lot number 21104221A
Take action
Contact the company
📍Recalling firmSTAQ Pharma, Inc.14135 E 42nd Ave Ste 50 · Denver, CO 80239-5214
“STAQ Pharma recalls Hydro morphine syringes with incorrect labeling.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35243-staq-pharma-recalls-hydro-morphine-syringes-with-incorrect-labeling. Based on FDA recall #D-0633-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0633-2022%22&limit=1).
The FDA announced on Feb. 3, 2022, that STAQ Pharma, Inc. voluntarily recalled a limited number of HYDROmorphone HCl syringes incorrectly labeled as Morphine Sulfate PF. The agency classified the Class I recall due to the potential for medication error.
How to tell if you have it
Brand: STAQ Pharma
Product: HYDROmorphone HCl PF 10 mg/50 mL (0.2mg/mL) in NaCl, 50 mL Single Dose Syringe
NDC: 73177-0104-05
Lot Number: 21104221A
Expiration date: 05-22-2022
Quantity: 905 Syringes
The hazard
According to the FDA, a limited number of syringes containing HYDROmorphone HCl PF were incorrectly labeled as Morphine Sulfate PF with lot number 21104221A. This labeling mix-up creates a risk of incorrect medication administration.
Context
GovInfoNow's records show STAQ Pharma, Inc. has issued two other recalls since Nov. 29, 2023, including a Ketamine Injection recall on Oct. 9, 2025, for missing lot/exp dates and a ROPivacaine HCl Injection recall on Nov. 29, 2023, for leaking bags. Other recent recalls of similar products include Fresen Morphine Syringes (Aug. 4, 2026), Sun Pharmaceutical Perampanel Tablets (June 17, 2026), and American Health Packaging Buprenorphine Tablets (Aug. 19, 2026).
How to tell if you have this one
Check for lot number 21104221A on the syringe label. The product is a 50mL single-dose hydro morphine syringe with NDC 73177-0104-05.
Brand
STAQ Pharma
Category
Drug
FDA recall event · 2 products
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
Classification
Class I
Status
Terminated
Distribution
CO, OH, and TX.
Recall number
Product, codes & lots
Quantity
D-0633-2022
HYDROmorphone HCl PF 10 mg/50 mL (0.2mg/mL) in NaCl, 50 mL in 50 mL Single Dose Syringe, Rx only, STAQ Pharma, Inc., Denver, CO 80239, NDC: 73177-0104-05.; Lot Number: 21104221A, Expiration date: 05-22-2022
905 Syringes
D-0634-2022
Morphine Sulfate PF 25 mg/25mL (1 mg/mL) in NaCl, 25 mL in 30 mL Single Dose Syringe, Rx only, STAQ Pharma, Inc., Denver, CO 80239, NDC: 73177-0105-04.; Lot Number: 21104221A, Expiration date: 05-22-2022
n/a
Based on the official FDA remedy
What to do — step by step
Check Label
Verify the label shows hydro morphine HCl PF, not morphine sulfate PF.
Where it went and when
Where it was distributed
Distributed in 3 states.
Listed by the agency
Not listed
FDA distribution: “CO, OH, and TX.” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Colorado, Ohio, Texas.
Recall timeline
FDA terminated this recall 7 months after the firm started it.
1Firm started the recall
2Published in FDA’s Enforcement Report
3FDA classified it Class I
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0633-2022 (February 3, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0633-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.